These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 5384468)
1. Response to therapy of spontaneous, first passage, and long passage lines of AK leukemia. Skipper HE; Schabel FM; Trader MW; Laster WR Cancer Chemother Rep; 1969 Dec; 53(6):345-66. PubMed ID: 5384468 [No Abstract] [Full Text] [Related]
2. Comparative chemotherapy of AKR lymphoma and human hematological neoplasia. Frei E; Schabel FM; Goldin A Cancer Res; 1974 Jan; 34(1):184-93. PubMed ID: 4520419 [No Abstract] [Full Text] [Related]
3. The chemotherapy of human and animal acute leukemia. Goldin A; Sandberg JS; Henderson ES; Newman JW; Frei E; Holland JF Cancer Chemother Rep; 1971 Nov; 55(4):309-505. PubMed ID: 4945857 [No Abstract] [Full Text] [Related]
4. Spontaneous AK leukemia (lymphoma) as a model for human leukemias and lymphomas. Skipper HE; Schabel FM Cancer Chemother Rep 3; 1972 May; 3(1):3-5. PubMed ID: 4340386 [No Abstract] [Full Text] [Related]
5. Combined effects of antineoplastic agents and anti-lymphoma allograft reactions. Riccardi C; Bartocci A; Puccetti P; Spreafico F; Bonmassar E; Goldin A Eur J Cancer (1965); 1980 Jan; 16(1):23-33. PubMed ID: 7358077 [No Abstract] [Full Text] [Related]
6. Antitumor activity of cyclocytidine in a variety of tumors. Hoshi A; Kanzawa F; Kuretani K Gan; 1972 Jun; 63(3):353-60. PubMed ID: 5072834 [No Abstract] [Full Text] [Related]
7. Characteristics and response to certain cancer chemotherapeutic agents of an acute lymphocytic leukemia arising in a BALB-c times DBA-2F1 mouse. Yancey ST; Bleyer WA Cancer Res; 1974 Aug; 34(8):1866-9. PubMed ID: 4526157 [No Abstract] [Full Text] [Related]
8. New agents and combination chemotherapy of non-Hodgkin's lymphoma. Skarin AT; Frei E; Moloney WC; Gutterman JU Br J Cancer Suppl; 1975 Mar; 2():497-504. PubMed ID: 52368 [No Abstract] [Full Text] [Related]
9. The use of long-term human leukocyte cell cultures as models for the study of antileukemic agents. Hirshaut Y; Weiss GH; Perry S Cancer Res; 1969 Sep; 29(9):1732-40. PubMed ID: 5258874 [No Abstract] [Full Text] [Related]
10. Electronic volume analysis of L1210 chemotherapy. Zucker RM; Helfman D Cancer Res; 1976 Dec; 36(12):4434-8. PubMed ID: 1000492 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of antileukemic agents in advanced leukemia L1210 in mice. IX. Kline I; Gang M; Tyrer DD; Venditti JM; Artis EW; Goldin A Cancer Chemother Rep 2; 1971 Apr; 2(1):65-133. PubMed ID: 5565539 [No Abstract] [Full Text] [Related]
12. Murine and human leukemias. Burchenal JH Bibl Haematol; 1975; (40):665-77. PubMed ID: 1100047 [TBL] [Abstract][Full Text] [Related]
13. Collateral sensitivity of resistant lines of mouse leukemias L1210 and L5178Y. Schmid FA; Hutchison DJ Cancer Res; 1972 Apr; 32(4):808-12. PubMed ID: 5014791 [No Abstract] [Full Text] [Related]
14. Sensitivity of transplantable rat leukemia, DBLA-6, to antitumor agents. Aoshima M; Sakurai Y Gan; 1972 Jun; 63(3):281-90. PubMed ID: 4116213 [No Abstract] [Full Text] [Related]
15. Cytarabine. Med Lett Drugs Ther; 1971 Jan; 13(1):3-4. PubMed ID: 5284023 [No Abstract] [Full Text] [Related]
16. Leukemia and lymphoma. White LP Geriatrics; 1970 Dec; 25(12):82-6. PubMed ID: 5274229 [No Abstract] [Full Text] [Related]
17. Immunochemotherapy of human cancer. Gutterman JU; Mavligit GM; Reed RC; Hersh EM Semin Oncol; 1974 Dec; 1(4):409-23. PubMed ID: 4620443 [No Abstract] [Full Text] [Related]